HomeBUSINESS
BUSINESS

Santen’s FY2015 Profits Zoom on Sale of RA Business
(May.13.2016)

Santen Pharmaceutical delivered a strong scorecard in FY2015 ended March, enjoying sharp gains in profits following the divestment of its rheumatoid arthritis business to Ayumi Pharmaceutical last year ...
(LOG IN FOR FULL STORY)